ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

The Impact of Anticoagulation Therapy Modifications during the Index Hospitalization on Clinical Outcomes in Kidney Transplant Recipients

J. Hardcopf, H. Meadows, N. Pilch, C. Perez, N. Patel, J. Fleming, H. Corbo, T. Harrison, B. O'Brien, D. DuBay, P. Baliga, D. Taber.

Medical University of South Carolina, Charleston, SC.

Meeting: 2018 American Transplant Congress

Abstract number: A215

Keywords: Anticoagulation, Kidney transplantation, Outcome

Session Information

Date: Saturday, June 2, 2018

Session Name: Poster Session A: Kidney: Cardiovascular and Metabolic

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall 4EF

Related Abstracts
  • The Price of Diabetes Medication Management in Kidney Transplantation: Similar Rates of Readmissions, but More Healthcare Utilization
  • Outcomes of Anticoagulation Use for Portal Vein Thrombosis in University of Wisconsin Liver Transplant Patients.

Background: The aim of this study was to determine whether changing anticoagulation medications during the index admission for kidney transplant (KT) is significantly associated with post-transplant outcomes.

Methods: Retrospective cohort study of adult KT recipients between 7/2015 and 7/2017. All patients that had an admission medication reconciliation at time of transplant verified by a pharmacist and were seen in clinic within 3 days of discharge by a pharmacist were included in this study. Medication lists were compared pre and post-transplant to identify changes. Outcomes included readmissions, rejection, graft loss and healthcare utilization. Overall utilization was defined as a composite of clinic visits, length of stay of hospitalizations and ED visits 90 days post-transplant. Anticoag med modifications were defined as an addition and/or deletion of anticoagulants such as warfarin or LMWH.

Results: 344 patients were included. Baseline characteristics were similar between groups, except for BMI (Table 1). 90-day (60% vs 27%, p=0.006) and 1-year readmissions (80% vs 38%, p=0.001) were significantly higher in those with anticoagulation modifications during transplant admission. Readmission etiologies demonstrated that KTs with anticoag modifications were readmitted predominately for surgical complications and medication related problems; time to readmission was significantly shorter in anticoag modifications patients as well (Table 2). Multivariable modeling demonstrated readmission risks associated with anticoag modifications remained significant after adjusted for baseline demographics (age, BMI, and KDPI). Overall utilization was not found to differ significantly in the 90 days post-transplant period (Table 2).

Conclusion: KTs undergoing modification of anticoagulation during the index hospitalization are at substantially higher risk for readmission. Focusing efforts to improve monitoring and management of these patients may mitigate risk.

CITATION INFORMATION: Hardcopf J., Meadows H., Pilch N., Perez C., Patel N., Fleming J., Corbo H., Harrison T., O'Brien B., DuBay D., Baliga P., Taber D. The Impact of Anticoagulation Therapy Modifications during the Index Hospitalization on Clinical Outcomes in Kidney Transplant Recipients Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Hardcopf J, Meadows H, Pilch N, Perez C, Patel N, Fleming J, Corbo H, Harrison T, O'Brien B, DuBay D, Baliga P, Taber D. The Impact of Anticoagulation Therapy Modifications during the Index Hospitalization on Clinical Outcomes in Kidney Transplant Recipients [abstract]. https://atcmeetingabstracts.com/abstract/the-impact-of-anticoagulation-therapy-modifications-during-the-index-hospitalization-on-clinical-outcomes-in-kidney-transplant-recipients/. Accessed March 8, 2021.

« Back to 2018 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.